How Healthcare CFOs Can Improve Financial Stability Without Cutting Patient Access

When cash tightens, healthcare CFOs face decisions that reach far beyond the finance department. Do you freeze hiring? Delay capital investments? Put expansion plans on hold? Before making decisions that could affect patient access, there's another question worth asking: Are we converting the revenue our operations produce into the cash we should be collecting?

That answer is often harder to find than it sounds.

A CFO can have an experienced finance team, capable revenue cycle staff, and detailed monthly reporting and still have revenue slipping away upstream. Financial statements show what happened. They don't always explain why net collection rate is falling, why A/R days are creeping upward, why denials keep recurring, or why the cost to collect continues to rise.

ABW Medical, a Savista company, approaches those questions from an operator's perspective. Our teams combine revenue cycle analytics with operational RCM expertise to identify where reimbursement is being delayed, reduced, or lost and trace those financial variances back to their source. That may mean uncovering an underpayment pattern, identifying the upstream cause of recurring denials, or finding workflows that create unnecessary touches and increase collection costs.

For CFOs, that visibility matters because improving financial performance starts with knowing which numbers are symptoms and which ones point to the real problem.

 

Look Beyond Days in A/R

Days in A/R matters, but CFOs need to understand what is driving it.

Consider two organizations reporting 48 Days in A/R. One may have a payer processing problem concentrated within a specific contract. The other may have charges sitting in hold queues because of documentation gaps, credentialing delays, or authorization failures. The KPI is identical. The financial problem isn't.

That's why experienced CFOs don't evaluate Days in A/R in isolation. They look at it alongside net collection rate, denial rate, A/R aging, underpayment trends, charge lag, cash collections, and cost to collect.

The relationship among those numbers often tells a more important story than any single KPI. Days in A/R could improve, for example, while net collection rate declines because balances are being written off rather than collected. A stable denial rate may also mask a growing underpayment problem because those claims are technically being paid.

Cost to collect adds another layer. If cash collections remain steady but require more staff touches, manual corrections, appeals, or vendor expense to produce the same result, the revenue cycle is becoming less efficient even though topline collections haven't changed.

For CFOs, the question isn't simply, "Are our KPIs improving?" It's whether the organization is converting the revenue it earns into cash efficiently and completely.

 

Find the Revenue That Never Becomes a Denial

Denials get attention because they're visible. Some of the most expensive revenue leakage never produces a denial at all.

A payer reimburses below the contracted rate. A provider begins seeing patients before enrollment is complete. Documentation supports a service that never makes it through charge capture. A secondary claim isn't submitted. An incorrect contractual adjustment closes a balance that should have been pursued.

In several of those situations, the claim may appear resolved in the billing system. Cash was received and the account was closed. From a traditional claims-management perspective, nothing appears wrong.

From a CFO's perspective, however, expected reimbursement and actual reimbursement don't match.

That's why revenue leakage analysis needs to extend beyond denial work queues. Payment and adjustment data can be analyzed for recurring variances by payer, service line, location, procedure, or other meaningful categories. When patterns emerge, the next step is determining whether the cause sits with payer behavior, contract configuration, documentation, coding, charge capture, or another operational workflow.

The objective isn't simply to recover individual underpayments after they happen. It's to identify patterns early enough to prevent revenue from continuing to leak out of the organization.

 

Measure the Cost of Slow Cash

For CFOs, collection performance isn't only about how much money eventually arrives. When it arrives and what it costs to collect matter too.

Every additional day revenue remains in A/R represents working capital the organization can't use for payroll, equipment, technology, expansion, or other priorities. Aging receivables can also become more expensive as they require additional follow-up and are more likely to encounter filing, appeal, or collectability challenges.

Consider a simplified example. If a healthcare organization generates $50 million in annual collectible revenue, a one-percentage-point improvement in net collection rate represents approximately $500,000 in additional cash, assuming the underlying collectible revenue remains the same. That improvement doesn't require another patient visit. It comes from capturing more of the reimbursement the organization has already earned.

Speed matters as well. ABW Medical reported that one client reduced total Days in A/R by 13% while charges increased 5%, and increased payments by 19%. Hold Days in A/R declined 38%. The results show why CFOs should look beyond volume and focus on how efficiently existing revenue moves through the cycle.

But faster cash shouldn't come at any cost. CFOs also need to watch cost to collect. If an organization improves collections only by adding staff, increasing outsourcing expense, or repeatedly reworking preventable denials, part of the financial gain is being consumed by the process required to produce it.

The better goal is to improve both cash conversion and the efficiency of collecting it.

 

Treat Revenue Cycle Variance as an Operational Signal

When the same denial category appears month after month, the answer usually isn't to work the denial faster.

The better question is: Why does the organization keep creating it?

Denial analytics can tell CFOs much more than how much money is sitting in a work queue. Patterns by payer, location, provider, service line, denial reason, or workflow can reveal where the underlying process is breaking down.

A recurring authorization denial may point upstream to scheduling or patient access. Eligibility-related denials may expose registration workflow problems. Coding denials may originate in provider documentation rather than the coding department itself.

Once the root cause is understood, leadership can assign operational ownership and measure whether corrective action actually changes the financial outcome.

That changes the role of denial management. Instead of repeatedly paying people to correct the same downstream problem, the organization uses denial data to prevent the next claim from failing.

For the CFO, prevention has two financial benefits: more earned revenue reaches cash, and fewer resources are spent recovering it.

That's the difference between managing A/R and managing the economics of the revenue cycle.

 

Protect Access by Improving Financial Visibility

Cost reduction will always be part of a CFO's toolkit, but some cuts create downstream consequences that eventually return to the finance department. Reducing patient access staff may increase registration errors. Pulling resources from authorization workflows may increase denials. Delaying provider credentialing support can postpone reimbursement even while the organization continues delivering care.

Before reducing resources that support patient access, CFOs should understand how much financial opportunity already exists within current operations.

That requires more than claims processing. It requires analytics that reveal where expected reimbursement isn't becoming cash, denial strategies focused on prevention rather than rework, disciplined identification of underpayments and other revenue leakage, and operational expertise that connects financial variances to the workflows creating them.

That's where ABW Medical, a Savista company, takes a different approach to RCM. We work with healthcare leaders to look beneath the headline metrics, understand what's driving financial performance, and address the operational causes behind lost or delayed revenue.

The goal isn't simply to get more claims paid. It's to improve net revenue realization, accelerate cash, reduce unnecessary collection expense, and give CFOs greater confidence in the financial performance of the organization.

Because protecting patient access doesn't always require finding more revenue somewhere else. Sometimes it starts by capturing more of the revenue you've already earned.

Get your free assessment today and discover how ABW Medical can help improve financial stability without cutting patient access.